The present study was performed to establish the socioepidemiological caracteristics (mean age, male to female ratio), the prevalence of various histological types of meningiomas in the groups of primary and recidivant tumors as well as Cathepsin d immunoexpression. We analysed 50 patients with primary and recidivant intracranial and intraspinal meningiomas who underwent surgery in KBC Zemun during the year 2004, with a two years follow-up. all surgical specimen were evaluated for histologic type of tumor and representative slides were immunostained with the anti-Cathepsin d antibody. In both primary and recidivant meningioma groups the number of mitosis, as factor tumor agressivness, was counted on 10 and 20 HPF and those results were statistically analyzed. a considerable difference was found when the number of mitosis and the histologic tumor grade have been compared with the Cathepsin d immunoexpression. The result lead to conlusion that the immunopositivity of Cathepsin d decreases with higher mitosis count and higher tumor grade. 
Introduction
Meningiomas are mostly benign nonglial tumors arising from arachnoidal cap cells of the brain and spinal coverings. They rappresent 30% of all primary brain tumors with an annual incidence of 4,5/100000 individuals 1 . Meningiomas tend to be numerous in the advanced age groups with a female prevalence of 2:1. spinal cord meningiomas show an even higher female to male prevalence (10:1) 2 . Interestingly, agressive and invasive forms of these tumors are more often found among males and children, besides their low pevalence in these groups .Meningiomas are slow growing tumors with increased intracranial pressure symptoms at presentation (headache, seizures, focal visual loss), allthoug signs of the disease dipend on their primary localization 1 . according to the WHO histological classification, meningiomas can be divided into three categories. The WHO grade I meningiomas are benign, usual non recurrent neoplasms with various histologic appearances. atypical meningiomas (WHO grade II) are more pleomorfic neoplasms with a higher tendency to invade the brain and to recurre. The WHO grade III tumors are malignant neoplasms that show increased cellular OrIGINaLNI radOVI abnormalities, tend to invade the microenvironment and metastasize to distant sites 3 . The incidence of recidiving tumors in this group is higher than in the former two groups. The most probable reason for tumor recurrence of the benign meningiomas (WHO grade I) is incomplete resection during surgery but atypical and malignant meningiomas (WHO groups II and III) tend to occur with a higer frequency even after a radical operation 4 . several studies point out that tumor invasion and infiltration of the surrounding brain tissue are the critical steps in determination of the biological behaviour of meningiomas. Invasion of tumor cells begins with adhesion to benign cells in proximity or adhesion to extracellular matrix proteins. subsequently, there is degradation of extracellular matrix protein which is considered to be a critical step in local tumor invasion. One of the enzimes responsible for degradation of matrix protein is a lysosomal cistein peptidase Cathepsin D 5 . since members of the same enzime family cathepsin B and L are involved in tumor invasion and infiltration, Cathepsin d also could play a role in the biological behaviour of agressive meningiomas, not only by degrading extracelular matrix but also by influencing tumor cell proliferation as well as tumor angiogenesis, indipendently of its proteolitical activity. a ``wild`` type od Cathepsin d has been demonstrated on the rat tumor cells 3Y1-ad 12.Only this wild enzime type inhibits tumor cell apoptosis contrary to nonmutated cathepsins, so it has been stated that Cathepsin d could exibit a protective activity against tumor cell apoptosis 6 .
Cathepsin d activity in intracranial tumor has not been a subject of many articles. The results of these studies differ from each other and are rather controversial, but several authors agree that Cathepsin d is overexpressed in benign meningiomas. as the tumor grade rises, the expression of Cathepsin d decreases 5,7,8, . The usefulness of this statment lays in the fact that targeted molecular therapy can be developped to prevent the loss of Cathepsin d activity in benigni meningiomas 5 .
Mitogenic activity of Cathepsin d in tumor cells has been thoroughly studied in relation with breast carcinoma but a similar role in meningioma is yet to be established 7 .
The aims of this study were to establish the socioepidemiological caracteristics of 50 meningioma patients treated at the Neurosurgery department of the Clinical Hospital Center Zemun, Belgrade as well as the histologic types of primary and recidivant tumors. We also analized the patterns of immunoexpression of Cathepsin d in relation with the tumor grade and agressivness.
Materials and methods
In our study, surgical specimen and complete medical documentation from 50 patients having primary and recidivant meningioma and who underwent surgical treatment during the year 2004.were used. We included patients having only meningiomas and no other benign or malignant neoplasms. a 2 year follow-up was performed. The complete medical documentation of those patients was available and so was the individual consent for the study. a two year period of follow-up was arranged. The surgical material was formalin fixed, paraffin-embedded and H&E slide were analized under 10x, 20x and 40x. One representative slide from each tumor was chosen for immunohistochemistry analysis. The tumors were graded according to the 2000 WHO classification. We estimated 15 criteria for meningioma grading (hypercellularity, nuclear atypia, nuclear hyperchromasia, small or prominent nucleoli, vesicular nuclei, mitoses on 10 and 20 HPF, small cells, clear cells, rhabdoid cells, papillary formations, endothelial proliferations, histologicaly established local brain invasion, focal or confluent necrosis) .all the above mentioned criteria were scored in a semiquantitative way except for the mitosis count which was graded in groups (0-4, 5-10, 11-20 and >20). recurrence free interval was defined as the period of time between the operation and the CT or MrI confirmation of an evident recidive. These data were analized using descriptive statistics and the relationship of the mitosis count and tumor grade was analized with the Mann Whitney nonparametric test.
For the purpose of the immunohistochemistry study, the tissue blocks were parafin-embedded and stained with the LsaB 2 system Horse raddish peroxidase. Positive control for Cathepsin d staining was normal tonsils and vocal cord tissue. The same tissues were used for negative control by omitting the primary antibody. The immunoanalysis was established by counting 1000 cells and the respective number of positive cells. These results was estimated by the Kruskal Wollis test.
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Results
In our study group there were 50 patients who underwent surgery for intracranial and intraspinal meningiomas. an evident female prevalence of 70% (35 female patients) was noted as well as a high percent od primary meningiomas among our patients, accounting for 82% (41 case) of 50 cases ( This relation of the mean age of diagnosis of primary and recidivant desease was similar in the female and male groups of patients. The mean reccurence free interval in our group was 4,33 years (2 to 8 years). a total of 64 meningioma specimen have been submitted to histological analysis ( one primary meningioma was multiple, 7 tumors recurred once, 1 tumor recurred twice and 1 meningioma recurred three times). The results of the pathohistologic analysis are shown in Table 3 . Most of the analysed tumors were graded as the WHO I group (57 cases). The remainder were classified as WHO II (5) Table 3 . Frequency of histologic types of meningiomas One tumor of the primary meningioma group was malignant while two were atypical. among the recidivant meningiomas, 2 (33,3%) were grade I tumors, 3 (50%) eningiomas were grade II and 1 (16,67%) was graded as WHO III. a detailed analysis of the histological parameters of atypical and malignant meningiomas was performed. Hypercellularity, atypia, prominent nucleoli, loss of vesicular nuclei and focal necrosis were present in 7 (10,9%) cases. architectural loss and hyperchomasia were noted in 6 (9,4%) of tumors. Brain invasion and invasion of distal structures was demonstrated in 2 cases (3,1%) respectivly.
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The mean mitosis count in both groups (primary and recidivant tumors) was 1 mitosis on HPF (0,98-1,19) . The Mann-Whitney test used to establish the relation between the mitosis count on 10 HPF in the groups of primary and recidivant meningioma, have not demonstrated any significant statistical difference. The average mitosis count on 20 HPF in the group of primary meningiomas was 1,74 and in the group of recidivant tumors was 3,1. The number of mitoses on 20 HPF was established by grading mitoses in groups (0-4. 5-10, 11-20 and >20) and then each group was analysed by the Mann Whitney test. The result was highly statistically significant (p<0,01) in the groups of primary and recidivant meningiomas (Table 4. ).
Meningioma
Total 
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The greatest number of tumors reactive for Cathepsin d were graded as WHO I and immunoreactivity in those cases was focal. Tumors of a higher invasive potencial (WHO II and III) reacted with Cathepsin d in a more diffuse way but their number was significantly lower (4 of these tumors were graded as WHO II and 1 as WHO III). This relation was analysed with the Kruskal-Wollis test and a statistically high difference was demonstrated. Benign meningiomas graded as the WHO I group were more immunoreactive to Cathepsin d than tumors of higher grade (p<0,05). In the majority of tumors the immunoexpression was diffuse (52 case or 91,23%), it was focal in most atypical meningiomas (4 cases or 80%) and in one case of malignant meningioma the staining was absent ( 
Discussion
Meningiomas are common in everyday neurosurgical and neuropathology practice, yet their origin as well as their biological behaviour still remain a riddle. several histologic classification have been in use but none of them, neither the newest WHO 2000 classification was completly satisfactory. In our study, a total of 50 OrIGINaLNI radOVI patients and 64 specimen of tumor were analysed. Primary meningiomas were present in 41 case (82%) while these neoplasms were recidivant in 9 patients (18%) 1, 4 . The male -female ratio of meningioma in the literature shows a 3:1 or even 2:1 relation with a female prevalence. In our study, we noted a 2,3:1 female to male ratio. The mean age in the group of our patients was 62 years, ranging from 46 to 79 years of age. This is consistent whit the literature data 2 . The ability to recurre is a feature typical of meningioma, the origin of which is yet to be established. Even after a complete resetion 5% of all meningiomas recurre in the next 5 years and 7-20% are recidivant after 20 years. Tumors graded as WHO group II are particularly intresting because 40% of these tumors shall present a recidive in the first 5 years after surgery. several factors were taken in consideration to explain this property of atypical meningiomas and the widness of the resection margins are thought to be of extreme importance to prevent reurrence 4 . In our study, only 9 patients had meningioma recurrence so this number was not representative for estimation of surgical resetion margins. during the followup period of 2 years, none of the primary meningiomas have recurred. One patient with a malignant meningioma died during the work on this study.
The histological type of meningiomas in our study group were consistent whit their distribution established by other authors. The more numerous among the primary meningiomas were WHO grade I, while in the recurrent neoplasms group 50% of them were grade II (3 cases). Tumors graded as WHO II make 20% of all surgicaly removed meningiomas and are associated whit a high recurrence risk 1, 3 . atypical meningiomas were present in our study in 5(7,81%) cases and 2 malignant meningiomas were also diagnosed (3,21%). an important diagnostic criterion for distinguishing WHO grades I and II is increased proliferative index expressed as the number of mitosis higher than 4 on 10 consecutive high power fileds (HPF) 9 . The average mitosis count in our study was 1 (0,98-1,19) in both primary and recidivant meningioma group. We established that there was a high statistically significant difference of the mitosis count on 20 HPF between the primary and recidivant meningiomas. The importance of establishing the potential of recurrence lies in the fact that those patients require a thorough postoperative follow-up 3, 9 . since the difference in mitosis count was significant only on consecutive 20 HPF, we suggest that more diagnostic criteria must be included in the estimation of malignancy in meningiomas whose histological caracteristics are not clear.
The role of Cathepsin d in stimulation of micrometastasis growth in breast cancer was reported in several studies 7, 8, 10, 11 . Overexpression of Cathepsin d in invasive breast tumors facilitates the local basement membrane distruction and apoptosis inhibition 11, 12, 13 . This features are signs of a bad prognosis. similar effects can be demonstrated in melanocytic tumors 12 . In a glioblastoma multiforme series the Cathepsin d expression ranged from 15 to 50% of cases 13, 14 . a positive control can be brain stromal tissue, whose macrophages exibit a strong immunoreaction to Cathepsin d. Those cells help degradation of the extracellular matrix and myelin remnants.
several authors have investigated the relation between the tumor grade and the Cathepsin expression. Tews 13, 14 and sivaparvathi 15 , indipendently, have noted a higher reactivity to Cathepsin d in anaplastic astrocytomas and glioblastomas compared to astrocytomas of a lower grade and normal tissue. an opposite relation have been established by Warich et al 16 . They stated that Cathepsin d overexpression is present in astrocytomas of lower grades, rather than in high grade tumors. a different pattern of Cathepsin d expression have been found in several tumor types (astrocytomas, oligodendrogliomas, ependimomas, PNET and other tumors) by robson and collegues 17 . In a study of potential prognostic markers over a series of 44 meningiomas, performed by Gottschalk et al. 18 , tumors were graded as grade I (whitout malignancy) to grade IV (malignant meningiomas with focal sarcomatoid component). ''some'' degree of expression was noted but without any consistent corelation with histologic grade, mitotic index and proliferative potential. The level of Cathepsin d expression was measured in a series of meningiomas and breast carcinoma by Koehors et al 19 . This study confirmed a certain immunoexpression but it was 2,4 times lower in the meningioma group. No corelation was found between the Cathepsin d expression and expression of estrogen and progesteron receptors, even though all these markers are encoded by the same gene 19, 20 . The study of 86 meningiomas performed by Castilla et al. 22 confirmed a stronger expression of Cathepsin d in tumors of lower grade and lower mitotic and apoptotic potential. These results are consistent with the conclusion of our study which was confirmed with the Kruskal Wollis test (p<0,05). There are several earlier studies that report a higher level of OrIGINaLNI radOVI immunoexpression of Cathepsin d in higher grade meningiomas 16, 19 , in contrast with the results of the study performed by Castilla et al and of our study. a possible explanation of these different results can be the fact that functionally inactive Cathepsin d molecules have been stained or that there has happened a cross reaction with some other molecules that are overexpressed in higher grade tumors. a potential Cathepsin d disregulation in tumors of increasing grade could be an explanation for a weaker immunostaining in higer grade meningiomas. since Cathepsin d exibit a strong expression in benign meningiomas, it could not be used as a prognostic factor of malignancy and invasivness. On the contrary, the loss of positive staining could be an alert for a potentialy agressive biological behaviour. Cathepsin d could be used in immunopannels as a negative marker for atypical and malignant meningiomas.
Conslusion
The socioepidemiological caracteristics of our study group are consistent whit the incidence and prevalence of meningiomas noted by other authors. There was no significant difference in the mitosis count on 10 HPF between the primary and recidivant meningiomas but this difference was highly significant (p<0,01) when mitoses were counted on 20 HPF. Cathepsin d positive immunostaining was present in 62 (96,88%) tumors. Most of those tumors were biologicaly benign. a statistically significant difference of Cathepsin d immunostaining was found in relation with the mitoses count on 10 HPF (p<0,05), on 20 HPF (p<0,05) and with the tumor histological grade.
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